ד"ר אלעד בן מאיר

קישורים למחקרים ומאמרים

1. Yinon Y, Katorza E, Nassie DI, Ben-Meir E, Gindes L, Hoffmann C, Lipitz S, Achiron R, Weisz B.

Late diagnosis of fetal central nervous system anomalies following a normal second trimester anatomy scan. Prenat Diagn. 2013;33(10):929-34. doi: 10.1002/pd.4163.

2. Yinon Y, Ben-Meir E, Berezowsky A, Weisz B, Schiff E, Mazaki-Tovi S, Lipitz S.

Circulating angiogenic factors in monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome and selective intrauterine growth restriction.

Am J Obstet Gynecol. 2014;210(2):141.e1-7. doi: 10.1016/j.ajog.2013.09.022.

3. Yinon Y, Ben-Meir E*, Margolis L, Lipitz S, Schiff E, Mazaki-Tovi S, Simchen MJ.

Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor. Placenta. 2015;36(2):121-4. doi: 10.1016/j.placenta.2014.12.008.

*- Equal contribution

4. Ben-Meir E, Rubinshtein M, Pessach I, Barkai G, Keller N, Hoffman C, Feldman Z, Paret G.

Neonatal Cervical Osteomyelitis with bilateral upper limb paresis. Pediatr Infect Dis J. 2017;36(10):1013-1015. doi: 10.1097/INF.0000000000001618.

5. Cohen-Cymberknoh M, Ben-Meir E*, Gartner S, Reiter J, Spangenberg A, Garriga L, Eisenstadt I, Israeli T, Tsabari R, Shoseyov D, Gileles-Hillel A, Breuer O, Simanovsky N, Kerem E. How abnormal is the normal? Clinical characteristics of CF patients with normal FEV1. Pediatr Pulmonol. 2021;56(7):2007-2013. doi: 10.1002/ppul.25371.

*- Equal contribution

6. Nissen G, Ben-Meir E*, Kopp M, Shaw M, Ratjen F, Grasemann H. Interleukin-1 beta is a potential mediator of airway nitric oxide deficiency in cystic fibrosis. J Cyst Fibros. 2022;S1569-1993(22)00049-2. doi: 10.1016/j.jcf.2022.02.017.

*- Equal contribution

7. Ben-Meir E, Grasemann H. How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease be Monitored? Am J Respir Crit Care Med. Am J Respir Crit Care Med. 2022;206(3):240-242. doi: 10.1164/rccm.202204-0730ED.

8. Ben-Meir E, Perrem L, Shaw M, Ratjen F, Grasemann H. SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros. 2024; S1569-1993(24)00024-9. doi: 10.1016/j.jcf.2024.02.009.

9. Ben-Meir E, Antounians L, Eisha S, Ratjen F, Zani A, Grasemann H. Extracellular vesicles in sputum of children with cystic fibrosis pulmonary exacerbations. ERJ Open Res. 2024;10(6):00547-2024. doi: 10.1183/23120541.00547-2024.

10. Gordon O, Mohamad H, Guzner N, Cohen Y, Ben-Meir E, Samman N, Sergienko R, Wolf DG, Picard E, Kerem E, Shamriz O. Risk factors for developing Adenovirus-associated post-infectious bronchiolitis obliterans. Pediatr Pulmonol. 2025;60(1):e27411. doi: 10.1002/ppul.27411.

11. Hadhud M, Halevy D, Reiter J, Ben-Meir E, Gileles-Hillel A, Sadras I, Kerem E, Cohen-Cymberknoh M, Breuer O. Long-term outcomes in people with CF lacking FEV1 response to elexacaftor/tezacaftor/ivacaftor therapy. J Cyst Fibros. 2025; S1569-1993(25)01486-9. doi: 10.1016/j.jcf.2025.05.005.

12. Ben-Meir E, Perrem L, Nissen G, Shaw M, Ratjen F, Hartmut Grasemann H. Sputum Biomarkers of Inflammation to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis. Int J Mol Sci. 2026 Feb 6;27(3):1616. doi: 10.3390/ijms27031616.